GBIO
GBIO
NASDAQ · Biotechnology

Generation Bio Co

$5.34
-0.40 (-6.97%)
As of Nov 7, 2:40 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +226.6% upside
Low Target $9.95
Average Target $17.44
High Target $18.08
Current Price $5.34
Current
$5.34
Target
$17.44
$9.95 $17.44 avg $18.08
Scenario Analysis
Bear Case
$9.95
86.3%
Low target
Base Case
$17.44
+226.6%
Avg target
Bull Case
$18.08
+238.6%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$5.89
-9.3% from high
52-Week Low
$4.91
+8.8% from low
Target vs 52W High
$17.44
+196.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%